forstoringsglas

Search results

Vinge has advised SBB in connection with the sale of properties to a company co-owned with Kåpan

Vinge has advised Samhällsbyggnadsbolaget i Norden AB (”SBB”) in connection with the sale of properties for SEK 10 billion to a company co-owned by Kåpan with a focus on government infrastructure.
November 19, 2021

Vinge has advised VNV Global in connection with a directed share issue

Vinge has advised VNV Global in connection with a directed share issue amounting to approximately SEK 1,191 million at a subscription price of SEK 123 per share.
November 19, 2021

Vinge advises Norditek in conjunction with its listing on Nasdaq First North

Vinge has advised Norditek Group AB in connection with its listing on Nasdaq First North Growth Market. The first day of trading is 10 November 2021. In connection with the listing, an invitation to subscribe for shares for a subscription price of SEK 11 was implemented, which was significantly oversubscribed by approximately 4.5 times.
November 10, 2021

Vinge acts as lead advisor to EQT in connection with its acquisition of Life Sciences Partners

Vinge acts as lead advisor to EQT AB in connection with its acquisition of Life Sciences Partners, a leading European life sciences venture capital firm with approximately EUR 2.2 billion of assets under management
November 10, 2021

Vinge has advised Hexatronic Group AB (publ) in connection with a directed share issue

Vinge has advised Hexatronic Group AB (publ) in connection with a directed share issue whereby the company receives approximately SEK 550 million in gross issue proceeds.
November 09, 2021

Vinge has advised Tobii AB (publ) in connection with a directed share issue

Vinge has advised Tobii AB in connection with a directed share issue whereby the company receives approximately SEK 300 million in gross issue proceeds.
November 08, 2021

Vinge has advised Xpray Pharma in connection with share issue

Vinge has advised Xspray Pharma, a pharmaceutical company with several product candidates in clinical development listed on Nasdaq Stockholm, in connection with a share issue whereby the company raises proceeds of approximately SEK 100 million.
November 08, 2021

Vinge advises 24Storage on the public offer from T-C Storage BidCo

T-C Storage BidCo AB has announced a public offer to the shareholders of 24Storage AB (publ). The total value of the offer is approx. SEK 925 million.
November 08, 2021

Vinge advises XVIVO in connection with a directed share issue of MSEK 250

Vinge has advised XVIVO Perfusion AB in connection with a directed new issue of shares to Swedish and international investors that contributed MSEK 250 to XVIVO.
November 01, 2021

Vinge advises Smart Eye in connection with a capital procurement of MSEK 220

Vinge has advised Smart Eye Aktiebolag in connection with a directed new issue of shares to Swedish and international investors that contributed MSEK 220 to Smart Eye.
November 01, 2021

Vinge has advised Sequoia Capital India in connection with Truecaller’s IPO on Nasdaq Stockholm

Vinge advised Sequoia Capital India in connection with the approx. SEK 19.4 bn IPO of Truecaller on Nasdaq Stockholm.
October 28, 2021

Vinge has advised Biotage in connection with its acquisition of ATDBio

Vinge has advised Biotage AB (publ), listed on Nasdaq Stockholm, in connection with its acquisition of ATDBio Limited based in Oxford and Southampton, UK, for a total purchase price of approx. 45 MGBP on a debt free and cash free basis (corresponding to approx. 534.4 MSEK) financed through a combination of a share issue of new ordinary Biotage shares, cash at hand and a revolving credit facility. The transaction closed in connection with the entering into of the share purchase agreement.
October 26, 2021

Vinge advises Isofol in connection with its listing on Nasdaq Stockholm

Vinge has advised Isofol Medical AB in connection with its listing on Nasdaq Stockholm, with the first day of trading on 21 October 2021. The prospectus was approved by the Swedish Financial Supervisory Authority on 18 October 2021. Isofol has a market value corresponding to approximately SEK 1.5 billion.
October 21, 2021

Vinge has advised Flat Capital AB (publ) in connection with its listing on Nasdaq First North Growth Market

Vinge has advised Flat Capital AB (publ) (“Flat Capital” or the “Company”) in connection with its listing on Nasdaq First North Growth Market. The prospectus was published on 29 September 2021 and the first day of trading on Nasdaq First North Growth Market was 20 October 2021.
October 20, 2021

Vinge has advised Byggfakta in connection with its listing on Nasdaq Stockholm

The first day of trading on Nasdaq Stockholm large cap was 15 October 2021. The offer price was SEK 75 per share, equivalent to a market value for the Byggfakta Group of approximately SEK 16.4 billion. The offer covers 64,483,197 shares together with an oversubscription option to a total value of approximately SEK 5.5 billion.
October 15, 2021
Previous Next